Ylermi Soini
Professori, Emeritus
ylermi.soini@uef.fi
Tutkimusryhmät
Julkaisut
150/150 kappaletta-
Claudin 6 is associated with a short survival and a short recurrent free interval in non-small cell lung carcinoma
Soini, Ylermi; Pirinen, Risto; Takasawa, Kumi; Osanai, Makoto; Takasawa, Akira. 2022. Polish Journal of pathology. 73: 1-5 -
Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas
Uotila, PM; Lemma, SA; Haapasaari, KM; Porvari, K; Skarp, S; Soini, Y; Jantunen, E; Turpeenniemi-Hujanen, T; Kuittinen, O. 2020. Hematology. 25: 241-246 -
Alterations in the expression of EMT-related proteins claudin-1, -4 and -7, E-cadherin, TWIST1 and ZEB1 in oral lichen planus
Hämäläinen, Lasse; Soini, Ylermi; Pasonen-Seppänen, Sanna; Siponen, Maria. 2019. Journal of oral pathology and medicine. 48: 735-744 -
Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer
Jääskeläinen, A; Jukkola, A; Haapasaari, KM; Auvinen, P; Soini, Y; Karihtala, P. 2019. Anticancer research. 39: 5879-5890 -
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP
Kari, E; Teppo, HR; Haapasaari, KM; Kuusisto, MEL; Lemma, A; Karihtala, P; Pirinen, R; Soini, Y; Jantunen, E; Turpeenniemi-Hujanen, T; Kuittinen, O. 2019. Journal of clinical pathology. 72: 316-321 -
Twist and Zeb1 expression identify Mycosis fungoides patients with low risk of disease progression
Häyrinen, MJ; Uotila, PM; Sahi, H; Haapasaari, KM; Teppo, HR; Soini, Y; Lapela, M; Vasala, K; Turpeenniemi-Hujanen, T; Ranki, A; Kuusisto, MEL; Kuittinen, O. 2019. Journal of the european academy of dermatology and venereology. 2020; 34: e95-e98 -
Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas
Valkonen, Mari; Haapasalo, Hannu; Rilla, Kirsi; Tyynelä-Korhonen, Kristiina; Soini, Ylermi; Pasonen-Seppänen, Sanna. 2018. Bmc cancer. 18: 664 -
Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival
Karihtala, P; Porvari, K; Soini, Y; Eskelinen, M; Juvonen, P; Haapasaari, KM. 2018. Oncology. 2019; 96: 164-170 -
High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
Jääskeläinen, Anniina; Soini, Ylermi; Jukkola-Vuorinen, Arja; Auvinen, Päivi; Haapasaari, Kirsi-Maria; Karihtala, Peeter. 2018. Bmc cancer. 18: 223 -
KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinoma
Isohookana, J; Haapasaari, KM; Soini, Y; Karihtala, P. 2018. Anticancer research. 38: 2295-2302 -
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
Peroja, P; Pedersen, M; Mantere, T; Nørgaard, P; Peltonen, J; Haapasaari, KM; Böhm, J; Jantunen, E; Turpeenniemi-Hujanen, T; Rapakko, K; Karihtala, P; Soini, Y; Vasala, K; Kuittinen, O. 2018. Scientific reports. 8: 14814 -
NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas
Haapasalo, Joonas; Nordfors, Kristiina; Granberg, Kirsi J; Kivioja, Tomi; Nykter, Matti; Haapasalo, Hannu; Soini, Ylermi. 2018. Histology and histopathology. 33: 791-801 -
Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers
Almangush, A; Heikkinen, I; Bakhti, N; Mäkinen, LK; Kauppila, JH; Pukkila, M; Hagström, J; Laranne, J; Soini, Y; Kowalski, LP; Grénman, R; Haglund, C; Mäkitie, AA; Coletta, RD; Leivo, I; Salo, T. 2018. Histopathology. 72: 1128-1135 -
Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma
Isohookana, Joel; Haapasaari, Kirsi-Maria; Soini, Ylermi; Leppänen, Joni; Karihtala, Peeter. 2018. Pathology research and practice. 214: 840-847 -
R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma
Prusila, Roosa Enni Inkeri; Haapasaari, Kirsi-Maria; Marin, Katja; Pollari, Marjukka; Soini, Ylermi; Vornanen, Martine; Karjalainen-Lindsberg, Marja-Liisa; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi. 2018. Acta oncologica. 57: 1265-1267 -
Small oral tongue cancers (less than or equal to 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cance
Almangush, A; Mäkitie, AA; Mäkinen, LK; Kauppila, JH; Pukkila, M; Hagström, J; Laranne, J; Soini, Y; Kowalski, LP; Grénman, R; Haglund, C; Coletta, RD; Salo, T; Leivo, I. 2018. Virchows archiv. 473: 481-487 -
An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma
Hintsala Hanna-Riikka, Haapasaari Kirsi-Maria, Soini Ylermi, Karihtala Peeter. 2017. Histology and histopathology. 32: 129-136 -
Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies
Almangush Alhadi, Leivo Ilmo, Siponen Maria, Sundquist Elias, Mroueh Rayan, Mäkitie Antti A, Soini Ylermi, Haglund Caj, Nieminen Pentti, Salo Tuula. 2017. Virchows archiv. 2018; 472: 231-236 -
Expression of thioredoxin, 8Hydroxy-deguanosine and peroxiredoxins in placental tissues
Pirinen Elina, Soini Ylermi. 2017. International journal of clinical and experimental pathology. 10: 8353-8360 -
Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma
Lemma Siria A, Kuusisto Milla, Haapasaari Kirsi-Maria, Sormunen Raija, Lehtinen Tuula, Klaavuniemi Tuula, Eray Mine, Jantunen Esa, Soini Ylermi, Vasala Kaija, Böhm Jan, Salokorpi Niina, Koivunen Petri, Karihtala Peeter, Vuoristo Jussi, Turpeenniemi-Hujanen Taina, Kuittinen Outi. 2017. Carcinogenesis. 38: 812-820 -
Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients
Bur Hamid, Haapasaari Kirsi-Maria, Turpeenniemi-Hujanen Taina, Kuittinen Outi, Auvinen Päivi, Marin Katja, Soini Ylermi, Karihtala Peeter. 2017. Leukemia & lymphoma. 2018; 59: 679-689 -
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Teppo Hanna-Riikka, Soini Ylermi, Karihtala Peeter. 2017. Oxidative medicine and cellular longevity. 2017: 1485283 -
Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
Karihtala Peeter, Porvari Katja, Soini Ylermi, Haapasaari Kirsi-Maria. 2017. Oxidative medicine and cellular longevity. 2017: 2696071 -
Tenascin-C and fibronectin expression divide early stage tongue cancer into low-and high-risk groups
Sundquist E, Kauppila JH, Veijola J, Mroueh R, Lehenkari P, Laitinen S, Risteli J, Soini Y, Kosma V-M, Sawazaki-Calone I, MacEdo CCS, Bloigu R, Coletta RD, Salo T. 2017. British journal of cancer. 116: 640-648 -
Cyclins A, B, E and p27 in Endometrial Endometrioid Adenocarcinoma
Santala S, Talvensaari-Mattila A, Soini Y, Kuvaja P, Santala M. 2016. Anticancer research. 36: 6467-6473 -
Epigenetic and genetic changes in soft tissue sarcomas: a review
Soini Ylermi. 2016. Apmis. 124: 925-934 -
Mesotheliomas show higher hyaluronan positivity around tumor cells than metastatic pulmonary adenocarcinomas
Törrönen Kari, Soini Ylermi, Pääkkö Paavo, Parkkinen Jyrki, Sironen Reijo, Rilla Kirsi. 2016. Histology and histopathology. 31: 1113-1122 -
Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma
Hintsala Hanna-Riikka, Jokinen Elina, Haapasaari Kirsi-Maria, Moza Monica, Ristimäki Ari, Soini Ylermi, Koivunen Jussi, Karihtala Peeter. 2016. Anticancer research. 36: 1497-1506 -
Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma
Bur Hamid, Haapasaari Kirsi-Maria, Turpeenniemi-Hujanen Taina, Kuittinen Outi, Auvinen Päivi, Marin Katja, Soini Ylermi, Karihtala Peeter. 2016. Anticancer research. 36: 4677-4683 -
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS
Fiore Danilo, Donnarumma Elvira, Roscigno Giuseppina, Iaboni Margherita, Russo Valentina, Affinito Alessandra, Adamo Assunta, De Martino Fabio, Quintavalle Christina, Romano Giulia, Greco Adelaide, Soini Ylermi, Brunetti Arturo, Croce Carlo M, Condorelli Gerolama. 2016. Oncotarget. 7: 19531-47 -
A simple novel prognostic model for early stage oral tongue cancer
Almangush A, Coletta RD, Bello IO, Bitu C, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Tommola S, Soini Y, Kosma V-M, Koivunen P, Kowalski LP, Nieminen P, Grénman R, Leivo I, Salo T. 2015. International journal of oral and maxillofacial surgery. 44: 143-150 -
Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors
Nissi Ritva, Talvensaari-Mattila Anne, Kuvaja Paula, Pääkkö Paavo, Soini Ylermi, Santala Markku. 2015. Anticancer research. 35: 973-976 -
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study
Harjama Liisa, Kuitunen Hanne, Turpeenniemi-Hujanen Taina, Haapasaari Kirsi Maria, Leppä Sirpa, Mannisto Susanna, Karjalainen-Lindsberg Marja-Liisa, Lehtinen Tuula, Eray Mine, Vornanen Martine, Haapasalo Hannu, Soini Ylermi, Jantunen Esa, Nousiainen Tapio, Vasala Kaija, Kuittinen Outi. 2015. Acta oncologica. 54: 939-943 -
Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcinoma
Santala Simi, Talvensaari-Mattila Anne, Soini Ylermi, Santala Markku. 2015. Anticancer research. 35: 3393-3397 -
Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment
Hanna-Riikka Hintsala, Ylermi Soini, Kirsi-Maria Haapasaari, Peeter Karihtala. 2015. Histopathology. 67: 348-357 -
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality
Almangush Alhadi, Bello Ibrahim O, Coletta Ricardo D, Mäkitie Antti A, Mäkinen Laura K, Kauppila Joonas H, Pukkila Matti, Hagström Jaana, Laranne Jussi, Soini Ylermi, Kosma Veli-Matti, Koivunen Petri, Kelner Natalie, Kowalski Luiz Paulo, Grénman Reidar, Leivo Ilmo, Läärä Esa, Salo Tuula. 2015. Virchows archiv. 467: 39-46 -
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index
Kuusisto Milla Elvi Linnea, Haapasaari Kirsi-Maria, Turpeenniemi-Hujanen Taina, Jantunen Esa, Soini Ylermi, Peroja Pekka, Bloigu Risto, Karihtala Peeter, Kuittinen Outi. 2015. Journal of clinical pathology. 68: 552-556 -
Increased Peroxiredoxin 6 Expression Predicts Biochemical Recurrence in Prostate Cancer Patients After Radical Prostatectomy
Raatikainen S, Aaltomaa S, Kärjä V, Soini Y. 2015. Anticancer research. 35: 6465-6470 -
KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes
Hartikainen Jaana M, Tengström Maria, Winqvist Robert, Jukkola-Vuorinen Arja, Pylkäs Katri, Kosma Veli-Matti, Soini Ylermi, Mannermaa Arto. 2015. Clinical cancer research. 21: - -
Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
Isohookana Joel, Haapasaari Kirsi-Maria, Soini Ylermi, Karihtala Peeter. 2015. Diagnostic pathology. 10: - -
SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma
Jouppila-Mättö Anna, Mannermaa Arto, Sironen Reijo, Kosma Veli-Matti, Soini Ylermi, Pukkila Matti. 2015. Histology and histopathology. 30: 569-579 -
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study
Lemma Siria A, Pasanen Anna Kaisa, Haapasaari Kirsi-Maria, Sippola Antti, Sormunen Raija, Soini Ylermi, Jantunen Esa, Koivunen Petri, Salokorpi Niina, Bloigu Risto, Turpeenniemi-Hujanen Taina, Kuittinen Outi. 2015. European journal of haematology. [epub ahead of print 7 AUG 2015]: - -
Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naive triple negative breast cancer and renal cell carcinoma
Mella Mikko, Kauppila Joonas H, Karihtala Peeter, Lehenkari Petri, Jukkola-Vuorinen Arja, Soini Ylermi, Auvinen Päivi, Vaarala Markku H, Ronkainen Hanna, Kauppila Saila, Haapasaari Kirsi-Maria, Vuopala Katri S, Selander Katri S. 2015. Oncoimmunology. 4: - -
Twist predicts poor outcome of patients with astrocytic glioma
Nordfors Kristiina, Haapasalo Joonas, Mäkelä Katri, Granberg Kirsi J, Nykter Matti, Korja Miikka, Paavonen Timo, Haapasalo Hannu, Soini Ylermi. 2015. Journal of clinical pathology. [epub ahead of print 10 July 2015]: - -
Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function
Virtakoivu Reetta, Mai Anja, Mattila Elina, De Franceschi Nicola, Imanishi Susumu Y., Corthals Garry, Kaukonen Riina, Saari Markku, Cheng Fang, Torvaldson Elin, Kosma Veli-Matti, Mannermaa Arto, Muharram Ghaffar, Gilles Christine, Eriksson John, Soini Ylermi, Lorens James B., Ivaska Johanna. 2015. Cancer research. 75: 2349-2362 -
A survey of zeb1, twist and claudin 1 and 4 expression during placental development and disease
Pirinen Elina, Soini Ylermi. 2014. Apmis. 122: 530-538 -
Claudins as prognostic factors for renal cell cancer
Virman Juha, Soini Ylermi, Kujala Paula, Luukkaala Tiina, Salminen Tapio, Sunela Kaisa, Kellokumpu-Lehtinen Pirkko-Liisa. 2014. Anticancer research. 34: 4181-4187 -
Depth of invasion, tumor budding and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer
Almangush Alhadi, Bello Ibrahim O, Keski-Säntti Harri, Mäkinen Laura K, Kauppila Joonas H, Pukkila Matti, Hagström Jaana, Laranne Jussi, Tommola Satu, Nieminen Outi, Soini Ylermi, Kosma Veli-Matti, Koivunen Petri, Grénman Reidar, Leivo Ilmo, Salo Tuula. 2014. Head and neck: journal for the sciences and specialties of the head and neck. 36: 811-818 -
High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma
Santala Simi, Talvensaari-Mattila Anne, Soini Ylermi, Honkavuori-Toivola Maria, Santala Markku. 2014. Tumor biology. 35: 5395-5399 -
Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival
Auvinen Päivi, Rilla Kirsi, Tumelius Ritva, Tammi Markku, Sironen Reijo, Soini Ylermi, Kosma Veli-Matti, Mannermaa Arto, Viikari Jukka, Tammi Raija. 2014. Breast cancer research and treatment. 143: 277-286 -
Increased nuclear factor erythroid 2-related factor 2 expression predicts worse prognosis of prostate cancer patients treated with radical prostatectomy
Raatikainen S, Aaltomaa S, Kärjä V, Soini Y. 2014. Human pathology. 45: 2211-2217 -
MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen
Tengström Maria, Mannermaa Arto, Kosma Veli-Matti, Soini Ylermi, Hirvonen Ari, Kataja Vesa. 2014. Acta oncologica. 53: 769-775 -
Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma
Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A, Karihtala P. 2014. Pathology research and practice. 210: 35-39 -
Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer
Tuomarila M, Luostari K, Soini Y, Kataja V, Kosma VM, Mannermaa A. 2014. PLoS ONE. 9: e109508: 1-8 -
Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas
Bur H, Haapasaari KM, Turpeenniemi-Hujanen T, Kuittinen O, Auvinen P, Marin K, Koivunen P, Sormunen R, Soini Y, Karihtala P. 2014. Histopathology. 65: 319-327 -
Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma
Santala Simi, Talvensaari-Mattila Anne, Soini Ylermi, Santala Markku. 2014. Tumor biology. 2015; 36: 953-957 -
Slug is associated with poor survival in squamous cell carcinoma of the lung
Merikallio H, Turpeenniemi-Hujanen TT, Pääkkö P, Mäkitaro R, Kaarteenaho R, Lehtonen S, Salo S, Salo T, Harju T, Soini Y.. 2014. International journal of clinical and experimental pathology. 7: 5846-5854 -
Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma
Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A, Karihtala P. 2014. Tumor biology. 35: 3803-3808 -
TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy
Raatikainen Sami, Aaltomaa Sirpa, Palvimo Jorma J, Kärjä Vesa, Soini Ylermi. 2014. Scandinavian journal of urology. 2015; 49: 51-7 -
miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer
Fernandez S, Risolino M, Mandia N, Talotta F, Soini Y, Incoronato M, Condorelli G, Banfi S, Verde P. 2014. Oncogene. 34: 3240-3250 -
Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma
Lemma S, Karihtala P, Haapasaari KM, Jantunen E, Soini Y, Bloigu R, Pasanen AK, Turpeenniemi-Hujanen T, Kuittinen O.. 2013. Histopathology. 62: 326-333 -
Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy
Pasanen AK, Haapasaari KM, Peltonen J, Soini Y, Jantunen E,. 2013. European journal of haematology. 91: 29-36 -
Claudin-7 expression and its association with tumor progression in systemic malignancies--reply
Lappi-Blanco E, Soini Y. 2013. Human pathology. 44: 1958-1959 -
Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin
Hintsala HR, Siponen M, Haapasaari KM, Karihtala P, Soini Y. 2013. International journal of clinical and experimental pathology. 6: 2855-63 -
Combination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinoma
Honkavuori-Toivola M, Santala M, Soini Y, Turpeenniemi-Hujanen T, Talvensaari-Mattila A. 2013. Disease markers. 35: 261-266 -
Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis
Lappi-Blanco E, Lehtonen ST, Sormunen R, Merikallio HM, Soini Y, Kaarteenaho RL. 2013. Human pathology. 44: 895-907 -
Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas
Nordfors K, Haapasalo J, Sallinen PK, Haapasalo H & Soini Y. 2013. Histology and histopathology. 28: 1137-1146 -
Expression of snail, twist, and Zeb1 in malignant mesothelioma
Merikallio H, Pääkkö P, Salmenkivi K, Kinnula V, Harju T, Soini Y.. 2013. Apmis. 121: 1-10 -
From metastases to the search of primary tumor
Soini Y. 2013. Duodecim. 129: 1097-101 -
GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma
Uimonen K, Merikallio H, Pääkkö P, Harju T, Mannermaa A, Palvimo J, Kosma VM, Soini Y. 2013. Histology and histopathology. : - -
Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer
Tuhkanen H, Hartikainen JM, Soini Y, Velasco G, Sironen R, Nykopp TK, Kataja V, Eskelinen M, Kosma VM, Mannermaa A.. 2013. International journal of cancer. 133: 2334-2340 -
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
Quintavalle C, Mangani D, Roscigno G, Romano G, Diaz-Lagares A, Iaboni M, Donnarumma E, Fiore D, De Marinis P, Soini Y, Esteller M & Condorelli G. 2013. PLoS ONE. Sep 19; 8 (9): e74466 -
Peroxiredoxins and their expression in ependymomas
Haapasalo T, Nordfors K, Järvelä S, Kok E, Sallinen P, Kinnula VL, Haapasalo HK & Soini Y. 2013. Journal of clinical pathology. 66: 12-7 -
Polarity of mature human odontoblasts
Tjäderhane L, Koivumäki S, Pääkkönen V, Ilvesaro J, Soini Y, Salo T, Metsikkö K, Tuukkanen J. 2013. Journal of dental research. 92: 1011-6 -
Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma
Quintero IB, Herrala AM, Araujo CL, Pulkka AE, Hautaniemi S, Ovaska K, Pryazhnikov E, Kulesskiy E, Ruuth MK, Soini Y, Sormunen RT, Khirug L, Vihko PT. 2013. PLoS ONE. 8: e73072 -
Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype
Karihtala P, Auvinen P, Kauppila S, Haapasaari KM, Jukkola-Vuorinen A, Soini Y. 2013. Breast cancer research and treatment. 138: 81-90 -
19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus
Stevens Kristen N, Fredericksen Zachary, Vachon Celine M, Wang Xianshu, Margolin Sara, Lindblom Annika, Nevanlinna Heli, Greco Dario, Aittomäki Kristiina, Blomqvist Carl, Chang-Claude Jenny, Vrieling Alina, Flesch-Janys Dieter, Sinn Hans-Peter, Wang-Gohrke Shan, Nickels Stefan, Brauch Hiltrud, Ko Yon-Dschun, Fischer Hans-Peter, Schmutzler Rita K. 2012. Cancer research. 72: 1795-1803 -
Claudins and Germ Cell Tumors
Soini Y. Teoksessa: Matin A(toim.) , 2012. Germ Cell Tumor. s. 135-150. Intech -
Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas.
Pasanen AK, Kuitunen H, Haapasaari KM, Karihtala P, Kyllönen H, Soini Y, Turpeenniemi-Hujanen T, Kuittinen O.. 2012. Leukemia & lymphoma. 53: 624-31 -
Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation
Soini, Y; Takasawa, A; Eskelinen, M; Juvonen, P; Kärjä, V; Hasegawa, T; Murata, M; Tanaka, S; Kojima, T; Sawada, N. 2012. Journal of clinical pathology. 65: 431-436 -
Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer
Hartikainen JM,Tengström M, Kosma VM, Kinnula VL, Mannermaa A, Soini Y.. 2012. Cancer research. 72: 5537-5546 -
High association of peroxiredoxins with lung cancer
Soini Y, Kinnula VL. 2012. Lung cancer. 78: 167 -
Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer.
Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, Palvimo J, Mannermaa A. 2012. Bmc cancer. 12: e1-15 -
Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma
Honkavuori-Toivola M, Talvensaari-Mattila A, Soini Y, Turpeenniemi-Hujanen T, Santala M. 2012. Tumor biology. 33: 935-941 -
Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer
Auvinen P, Tammi R, Kosma VM, Sironen R, Soini Y, Mannermaa A, Tumelius R, Uljas E, Tammi M. 2012. International journal of cancer. 132: 531-539 -
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
Tuomela J, Sandholm J, Karihtala P, Ilvesaro J, Vuopala K, Kauppila J, Kauppila S, Dongquan C, Pressey C, Härkönen P, Harris K, Graves D, Auvinen P, Soini Y, Jukkola-Vuorinen A, Selander K. 2012. Breast cancer research and treatment. 135: 481-493 -
Nivelet, luusto ja pehmytkudokset
Soini Y & Miettinen M. Teoksessa: Mäkinen Markus, Carpén Olli, Kosma Veli-Matti, Lehto Veli-Pekka, Paavonen Timo & Stenbäck Frej(toim.) , 2012. Patologia. s. 1094-1113. Kustannus Duodecim -
Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer
Merikallio H, Pääkkö P, Kinnula V.L, Harju T, & Soini Y. 2012. Human pathology. 43: 577-584 -
Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma
Peroja P, Pasanen A K, Haapasaari K-M, Jantunen E, Soini Y, Turpeenniemi-Hujanen T, Bloigu R, Lilja L, Kuittinen O, Karihtala P. 2012. Experimental hematology & oncology. 1: 2 -
Snail promotes an invasive phenotype in lung carcinoma
Merikallio H, Turpeenniemi-Hujanen T, Pääkkö P, Mäkitaro R, Riitta K, Salo S, Salo T, Harju T, Soini Y. 2012. Respiratory research. 13: - -
Sydän
Mäkinen M, Soini Y. Teoksessa: Mäkinen Markus, Carpén Olli, Kosma Veli-Matti, Lehto Veli-Pekka, Paavonen Timo & Stenbäck Frej(toim.) , 2012. Patologia. s. 375-411. Kustannus Duodecim -
TLR4 and TLR9 are induced in oral lichen planus
Siponen M, Kauppila JH, Soini Y, Salo T. 2012. Journal of oral pathology and medicine. 41: 741-747 -
Tight junctions in lung cancer and lung metastasis: a review
Soini Y. 2012. International journal of clinical and experimental pathology. 5: 126-136 -
Tiivisliitosproteiinit keuhkosyövässä ja keuhkosyövän metastaaseissa. (Tight junctions in lung cancer and metastasis
Soini Y. 2012. International journal of clinical and experimental pathology. 5: 126-36 -
Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together withnodal status
Kuvaja P, Hulkkonen S, Pasanen I, Soini Y, Lehtonen S, Talvensaari-Mattila A, Pääkkö P, Kaakinen M, Autio-Harmainen H, Hurskainen T, Lehenkari P &Turpeenniemi-Hujanen T. 2012. Experimental cell research. 318: 1091-1103 -
(Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
Peltonen T, Näpänkangas J, Ohtonen P, Aro J, Peltonen J, Soini Y, Juvonen T, Satta J, Ruskoaho H, Taskinen P. 2011. Atherosclerosis. 216: 35-43 -
8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma
Soini Y, Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, Kärjä V, Karihtala P. 2011. International journal of clinical and experimental pathology. 4: 267-75 -
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Yang Xiaohong R, Chang-Claude Jenny, Goode Ellen L, Couch Fergus J, Nevanlinna Heli, Milne Roger L, Gaudet Mia, Schmidt Marjanka K, Broeks Annegien, Cox Angela, Fasching Peter A, Hein Rebecca, Spurdle Amanda B, Blows Fiona, Driver Kristy, Flesch-Janys Dieter, Heinz Judith, Sinn Peter, Vrieling Alina, Heikkinen Tuomas et al. 2011. Journal of the national cancer institute. 103: 250-263 -
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne RL, Ignacio Arias J, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhov. 2011. Human molecular genetics. 20: 4693-4706 -
Claudins 1, 3M, 3S, 4, 5 and 7 in vulvar neoplasms compared with vulvar squamous cell carcinoma
Riski M, Santala M, Soini Y, Talvensaari-Mattila A. 2011. Tumor biology. 33: 537-542 -
Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers
Merikallio H, Pääkkö P, Harju T, Soini Y. 2011. International journal of clinical and experimental pathology. 4: 667-73 -
Claudins in lung diseases
Soini Ylermi. 2011. Respiratory research. 12: 70 -
Epigenetic regulation of miR-212 expression in lung cancer
Incoronato M, Urso L, Portela A, Laukkanen MO, Soini Y et al.. 2011. PLoS ONE. 6: e27722 -
Expression pattern of claudins 1 and 3-an auxiliary tool in predicting behavior of mucoepidermoid carcinoma of salivary gland origin
Aro Katri, Blumer Rosa Luiz Eduaro, Bello Ibrahim O, Soini Ylermi, Mäkitie Antti A, Salo Tuula, Leivo Ilmo. 2011. Virchows archiv. 458: 341-8 -
HIF-1α and VEGF are associated with disease progression in esophageal carcinoma
Takala H, Saarnio J, Wiik H, Ohtonen P, Soini Y. 2011. Journal of surgical research. 167: 41-8 -
Impact of smoking on the expression of claudins in lung carcinoma
Merikallio Heta, Kaarteenaho Riitta, Pääkkö Paavo, Lehtonen Siri, Hirvikoski Pasi, Mäkitaro Riitta, Harju Terttu, Soini Ylermi. 2011. European journal of cancer. 47: 620-30 -
Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.
Vehviläinen Piia, Koli Katri, Myllärniemi Marjukka, Lindholm Pamela, Soini Ylermi, Salmenkivi Kaisa, Kinnula Vuokko L, Keski-Oja Jorma. 2011. Human pathology. 42: 269-78 -
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Broeks, Annegien; Schmidt, Marjanka K; Sherman, Mark E; Couch, Fergus J; Hopper, John L; Dite, Gillian S; Apicella, Carmen; Smith, Letitia D; Hammet, Fleur; Southey, Melissa C; Van't Veer, Laura J; de Groot, Renate; Smit, Vincent T. H. B. M; Fasching, Peter A; Beckmann, Matthias W; Jud, Sebastian; Ekici, Arif B; Hartmann, Arndt; Hein, Alexander; Schulz-Wendtland, Ruediger et al.. 2011. Human molecular genetics. 20: 3289-3303 -
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
Karihtala P, Kauppila S, Soini Y, Arja-Jukkola-Vuorinen.. 2011. Bmc cancer. : 262 -
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
Takala H, Kauppila JH, Soini Y, Selander KS, Vuopala KS, Lehenkari PP, Saarnio J, Karttunen TJ.. 2011. Journal of innate immunity. 3: 631-8 -
Transcription factors zeb1, twist and snai1 in breast carcinoma
Soini Ylermi, Tuhkanen Hanna, Sironen Reijo, Virtanen Ismo, Kataja Vesa, Auvinen Päivi, Mannermaa Arto, Kosma Veli-Matti. 2011. Bmc cancer. 11: - -
Transcription of factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma
Jouppila-Mättö A, Tuhkanen H, Soini Y, Pukkila M, Närkiö-Mäkelä M, Sironen R, Virtanen I, Mannermaa A, Kosma V-M. 2011. Histology and histopathology. 26: 443-449 -
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression
Juoppila-Mättö Anna, Närkiö-Mäkelä Mervi, Soini Ylermi, Pukkila Matti, Sironen Reijo, Tuhkanen Hanna, Mannermaa Arto, Kosma Veli-Matti. 2011. Bmc cancer. 11: 350 -
Zep1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins
Merikallio Heta, Kaarteenaho Riitta, Pääkkö Paavo, Lehtonen Siri, Hirvikoski Pasi, Mäkitaro Riitta, Harju Terttu, Soini Ylermi. 2011. Journal of clinical pathology. 64: 136-40 -
Claudins 1, 11 and twist in meningiomas
Soini Y, Rauramaa T, Alafuzoff I, Sandell PJ, Kärjä V. 2010. Histopathology. 56: 821-824 -
Divergent effects of losartan and metoprolol on cardiac remodeling, C-kit + cells, proliferation and apoptosis in the left ventiricle after myocardial infarction
Serpi R, Tolonen AM, Tenhunen O, Pieviläinen O, Kubin AM, Vaskisuo T, Soini Y, Kerkelä R, Leskinen H & Ruskoaho H. 2010. Cts: clinical and translational science. 2: 422-430 -
Divergent expression of claudin -1, -3, -4, -5 and -7 in developing human lung
Kaarteenaho R, Merikallio H, Lehtonen S, Harju T & Soini Y. 2010. Respiratory research. 11: 59 -
Evaluation of neuroendocrine markers in renal cell carcinoma
Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P. 2010. Diagnostic pathology. 12: 28 -
GATA-4 is an angiogenic survival factor of the infarcted heart
Rysä J, Tenhunen O, Serpi R, Soini Y, Nemer M, Leskinen H & Ruskoaho H. 2010. Circulation: heart failure. 3: 440-450 -
Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma
Määttä M, Santala M, Soini Y, Turpeenniemi-Hujanen T & Talvensaari-Mattila A. 2010. Acta obstetricia et gynecologica scandinavica. 89: 380-384 -
Oxidate stress-induced antioxidant enzyme expression in an early phenomenon in ovarian carcinogenesis
Pylväs M, Puistola U, Kauppila S, Soini Y & Karihtala P. 2010. European journal of cancer. 46: 1661-1667 -
Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I)
Bello IO, Soini Y, Salo T. 2010. Oral oncology. 46: 630-635 -
Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II)
Bello IO, Soini Y, Salo T. 2010. Oral oncology. 46: 636-643 -
ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival
Kauppinen J, Kosma V-M, Soini Y, Sironen R, Nissinen M, Nykopp T, Kärjä V, Eskelinen M, Kataja V, Mannermaa A. 2010. Cancer epidemiology biomarkers and prevention. 19: 2133-2142 -
Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors
Järvelä S, Rantala I, Rodriquez A, Kallio H, Parkkila S, Kinnula VL & Soini Y. 2010. Bmc cancer. 22: 104 -
Twist is inversely associated with claudins in germ cell tumors of the testis
Väre P & Soini Y. 2010. Apmis. 118: 640-647 -
Apelin and its receptor APJ in human aortic valve stenosis
Peltonen T, Näpänkangas J, Vuolteenaho O, Ohtonen P, Soini Y, Juvonen T, Satta J, Ruskoaho H, Taskinen P. 2009. . 18: 644-652 -
Claudin-1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis
Kaarteenaho-Wiik R, Soini Y. 2009. Journal of histochemistry and cytochemistry. 57: 187-195 -
Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma
Turunen M, Talvensaari-Mattila A, Soini Y, Santala M. 2009. Anticancer research. 29: 5185-5189 -
DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma
Karihtala P, Soini Y, Vaskuvuo L, Bloigu R, Puistola U. 2009. . 19: 1047-1051 -
Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma
Lindholm P M, Soini Y, Myllärniemi M, Knuutila S, Heikinheimo M, Kinnula V L, Salmenkivi K. 2009. Journal of clinical pathology. : 339-344 -
Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis
Peltonen T, Taskinen P, Näpänkangas J, Leskinen H, Ohtonen P, Soini Y, Juvonen T, Satta J, Vuolteenaho O, Ruskoaho H. 2009. European heart journal. 30: 242-249 -
Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentation in renal cell carcinoma
Ronkainen H, Vaarala MH, Kauppila S, Soini Y, Paavonen TK, Rask J, Hirvikoski P. 2009. Oncology reports. 21: 1519-1523 -
Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
Tuhkanen H, Soini Y, Kosma V-M, Anttila M, Sironen R, Hämäläinen K, Kukkonen L, Virtanen I, Mannermaa A. 2009. Bmc cancer. 9: -
Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study
Pajala A, Melkko J, Leppilahti J, Ohtonen P, Soini Y, Risteli J. 2009. Histology and histopathology. 24: 1207-1211 -
Acute edematous and necrotic pancreatitis in a porcine model
Meriläinen S, Mäkelä J, Anttila V, Koivukangas V, Kaakinen H, Niemelä E, Ohtonen P, Risteli J, Karttunen T, Soini Y, Juvonen T. 2008. Scandinavian journal of gastroenterology. 2008: 1259-1268 -
Carbonic anhydrase IX in oligodendroglial brain tumors
Järvelä S, Parkkila S, Bragge H, Kähkönen M, Parkkila A-K, Soini Y, Pastorekova S, Pastorek J, Haapasalo H. 2008. Bmc cancer. 8: 1 -
Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas
Järvelä S, Nordfors K, Jansson M, Haapasalo J, Helén P, Paljärvi L, Kalimo H, Kinnula V, Soini Y, Haapasalo H. 2008. Journal of neuro-oncology. 90: 283-91 -
Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation?
Lehtonen ST, Ohlmeier S, Kaarteenaho-Wiik R, Harju T, Pääkkö P, Soini Y, Kinnula VL. 2008. Antioxidants and redox signaling. 10: 813-820 -
Expression of claudins 1, 4, 5, and 7 and occludin, and reletionship with prognosis in squamous cell carcinoma of the tongue
Bello IO, Vilen S-T, Niinimaa A, Kantola S, Soini Y, Salo T. 2008. Human pathology. 39: 1212-1220 -
Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity
Harju T, Mazur W, Merikallio H, Soini Y, Kinnula VL. 2008. Respiratory research. 9: 80 -
Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing
Seppinen L, Sormunen R, Soini Y, Elamaa H, Heljasvaara R, Pihlajaniemi T. 2008. Matrix biology. 27: 535-546 -
Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma
Väre P, Loikkanen I, Hirvikoski P, Vaarala MH, Soini Y. 2008. Oncology reports. 19: 25-31 -
Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma
Pennanen H, Kuittinen O, Soini Y, Turpeenniemi-Hujanen T. 2008. European journal of haematology. 81: 289-297 -
Thrombospondin-4 expression is rapidly upregulated by carciac overload
Mustonen E, Aro J, Puhakka J, Ilves M, Soini Y, Leskinen H, Ruskoaho H, Rysä J. 2008. Biochemical and biophysical research communications. 373: 186-191 -
A recurrent mutation in PALB2 in Finnish cancer families
Erkko Hannele, Bing Xia, Nikkilä Jenni, Schleutker Johanna, Syrjäkoski Kirsi, Mannermaa Arto, Kallioniemi Anne, Pylkäs Katri, Karppinen Sanna-Maria, Rapakko Katrin, Alexander Miron, Qing Sheng, Guilan Li, Mattila Henna, Daphene W. Bell. 2007. Nature -
Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis
Vakkala M, Laurila JJ, Saarnio J, Koivukangas V, Syrjälä H, Karttunen T, Soini Y, Ala-Kokko TI. 2007. Critical care. 11: R116 -
Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior
Takala H, Saarnio J, Wiik H, Soini Y. 2007. Apmis. 115: 838-847 -
Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
Harju TH, Peltoniemi MJ, Rytilä PH, Soini Y, Salmenkivi KM, Board PG, Ruddock LW, Kinnula VL. 2007. Respiratory research. 8: 48 -
Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation
Karihtala P, Soini Y, Auvinen P, Tammi R, Tammi M, Kosma V-M. 2007. Journal of histochemistry and cytochemistry. 55: 1191-1198